Anastrozole hydrochloride is mainly used to treat hormone receptor-positive breast cancer in women who have gone through menopause. It works by lowering the amount of estrogen produced in the body, which helps slow or stop the growth of cancer cells that rely on this hormone. It is grouped under the following drug class(es): Antineoplastic agents and Fertility agents. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include VYOGTZSNIVDKJK-UHFFFAOYSA-N and SCHEMBL3172308. Its PubChem CID is 11580739.
Anastrozole hydrochloride
| CAS No | 868771-60-2 |
|---|---|
| Molecular Formula | C17H20ClN5 |
| Molecular Weight | 329.8 g/mol |
| Synonyms | 2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Anastrozole hydrochloride is mainly used to treat hormone receptor-positive breast cancer in women who have gone through menopause. It works by lowering the amount of estrogen produced in the body, which helps slow or stop the growth of cancer cells that rely on this hormone.
The listed CAS number is 868771-60-2.
The listed molecular formula is C17H20ClN5.
The listed molecular weight is 329.8 g/mol.
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile;hydrochloride.
The source lists VYOGTZSNIVDKJK-UHFFFAOYSA-N and SCHEMBL3172308.